← Open Payments lookup

LINDSEY SIMMS: Open Payments

NPI 1518218411 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$534 in 33 payments from 14 companies in 2025. Trend: 2023 $535 · 2024 $701 · 2025 $534

Food & beverage: $534
CompanyPaymentsAmount
ABBVIE INC.15$190
Takeda Pharmaceuticals U.S.A., Inc.2$65
GENZYME CORPORATION2$42
Madrigal Pharmaceuticals2$37
Phathom Pharmaceuticals, Inc.3$36
Ardelyx, Inc.1$33
Janssen Biotech, Inc.1$21
Ipsen Biopharmaceuticals, Inc1$18
Aimmune Therapeutics, Inc.1$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$16

Products named: SKYRIZI, ENTYVIO, RINVOQ, DUPIXENT, CREON, REZDIFFRA, VOQUEZNA, IBSRELA.

Industry payments across LA — which companies pay providers there.